The largest database of trusted experimental protocols

9 protocols using pcdna3.1 v5 his topo ta

1

In vivo Transfection of YFP-LC32 and Fbxo21SMART-V5

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo transfection experiments used the yellow fluorescent protein (YFP)–LC32 (link) and Fbxo21SMART-V5 plasmids. For the cloning of mouse Fbxo21/SMART gene, muscle cDNA was amplified by PCR using the primers forward: 3′-ACCATGGCGTCGGTAGCGGGGGACA-5′ and reverse: 3′-CTCGGCTGTGTCCTCCTTTGCACTG-5′.
The amplified sequence was cloned into pcDNA3.1/V5-His TOPO TA (Invitrogen) expression vector and sequenced. The list of the antibodies is described in Supplementary Table 2.
Uncropped blots are shown in Supplementary Fig. 19.
+ Open protocol
+ Expand
2

Overexpression and detection of TLR2 protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
ggTLR2-1 gene sequence encoding the full-length ORF were ligated into the mammalian expression vector, pcDNA3.1/V5-His-TOPO TA (Invitrogen, Shanghai, China). The resulting plasmid was introduced into HEK-293 cells by transfection using Lipofectamine®-2000 (Invitrogen). After 24 hours of transfection, cells were lysed with lysis buffer (1% Nonidet P-40, 10 mM EDTA, 1 mg/ml iodoacetamide, 1 mM phenylmethylsulfonyl fluoride, 50 mM Tris maleate, pH 8.6) at a density of 1 × 107 cells/ml. Proteins of interest were separated by SDS-polyacrylamide gel electrophoresis [48 (link)], transferred to nitrocellulose membranes, and subjected to immunoblotting analysis with anti-His antibody (Abcam, Cambridge, UK). The antigen-antibody complex was detected using an ECL Kit (Amersham Pharmacia Biotech, Amersham, UK), following the manufacturer’s protocol.
+ Open protocol
+ Expand
3

Generation of ADAMTS13 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ADAMTS13 wild-type (WT) cDNA was subcloned into the mammalian expression vector pcDNA3.1/V5-His TOPO®TA (Invitrogen, Carlsbad, CA, USA). The nine ADAMTS13 variants (p.Val154Ile, p.Asp187His, p.Thr339Arg, p.Arg421Cys, p.Tyr603Cys, p.Asp836Gly, p.Arg925Gly, p.His1196Gln and p.Thr1249Pro) were separately introduced into the pcDNA3.1-ADAMTS13 WT expression vector by site-directed mutagenesis using PFU Turbo DNA polymerase (Stratagene, La Jolla, CA, USA) and specifically designed primers. The presence of each variant was confirmed by Sanger sequencing analysis.
+ Open protocol
+ Expand
4

Expression of Epitope-Tagged HAT Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney cells, HEK293T, and human cervical carcinoma cells, HeLa (ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle's media (Gibco, Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA). Full‐length human HAT cDNA in pCAGGS was generously provided by Dr. Eva Friebertshaeuser, Philipps University Marburg. The generation of human full‐length HATL‐5 cDNA in pcDNA 3.1/V5‐His TOPO® TA (Invitrogen, Life Technologies, Grand Island, NY) in frame with a C‐terminal HIS‐tag and V‐5 epitope has previously been described (Miller et al., 2014 (link)). A control vector, pcDNA 3.1‐GFP, was used to assess transfection efficiency and as a negative control for western blotting. Transfection of cells was performed using Lipofectamine LTX according to the manufacturer's instructions (Invitrogen, Life Technologies, Grand Island, NY). Transfections were performed with 2.5 μg plasmid DNA.
+ Open protocol
+ Expand
5

Overexpression of Human HAT and HATL-5 in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney cells, HEK293T, and human cervical carcinoma cells, HeLa (ATCC, Manassas, VA) were cultured in Dulbecco’s modified Eagle’s media (Gibco, Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA). Full-length human HAT cDNA in pCAGGS was generously provided by Dr. Eva Friebertshaeuser, Philipps University Marburg. The generation of human full-length HATL-5 cDNA in pcDNA 3.1/V5-His TOPO® TA (Invitrogen, Life Technologies, Grand Island, NY) in frame with a C-terminal HIS-tag and V-5 epitope has previously been described (Miller et al., 2014 (link)). A control vector, pcDNA 3.1-GFP, was used to assess transfection efficiency and as a negative control for western blotting. Transfection of cells was performed using Lipofectamine LTX according to the manufacturer’s instructions (Invitrogen, Life Technologies, Grand Island, NY). Transfections were performed with 2.5 μg plasmid DNA.
+ Open protocol
+ Expand
6

Cloning and Mutating NAA80 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NAA80 gene was inserted into vector pcDNA3.1/V5-His TOPO TA (Invitrogen), as we have described (7 (link)). The catalytically inactive mutant NAA80CM (W105F, R170Q, G173D, and Y205F) and other mutants (Fig. 4D) were generated using the Q5 Site-Directed Mutagenesis Kit (NEB). The NAA80 constructs were cloned into vector pcDNA4/HisMax TOPO TA (Invitrogen), in which the Xpress tag was replaced with a V5 tag. For imaging, NAA80FL and NAA80ΔN were cloned between the BglII and HindIII sites of vector EGFP-C1 (Clontech Laboratories).
+ Open protocol
+ Expand
7

Generation of Chimeric Immune Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Generation of CD16158F-CD8α-CD28-CD3ζ CR has previously been described.16 (link) The extracellular region of CD32A131R was amplified by reverse-transcriptase polymerase chain reaction (RT-PCR) from RNA extracted from peripheral blood mononuclear cells (PBMCs) utilizing the following primers: forward 5′-GAGAATTCACCATGACTATGGAGACCCAAATG-3′ and reverse 5′-CGTACGCCCCATTGGTGAAGAGCTGCC-3′ (Thermo Fisher Scientific, Waltham, MA). PCR product was fused by restriction enzyme-compatible ends with the CD8α-CD28-CD3ζ domain contained in the pcDNA3.1/V5-His TOPO TA (Invitrogen, Carlsbad, CA). CD16158F-CR and CD32131R-CR were subcloned into NcoI and MluI sites of the SFG retroviral vector. CD16158V and CD32A131H were assembled by using synthetic oligonucleotides. Fragments were separately inserted into SFG vector and sequenced by GeneArt Gene Synthesis team (Invitrogen-Thermo Fisher Scientific, Regensburg, Germany).
+ Open protocol
+ Expand
8

Porcine HSP70 Overexpression in IPEC-J2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Porcine HSP70 encoding sequences were ligated into mammalian expression vector pcDNA3.1/V5-His-TOPO TA, procured from Invitrogen (Shanghai, China). The plasmid DNAs were extracted with an endotoxin-free Plasmid Maxi Kit (Qiagen, Valencia, CA, USA). IPEC-J2 cells were incubated in a 6-well tissue culture plate in culture medium (DMEM-F12: Gibco, Grand Island, NY, USA) supplemented with 100 mg/mL streptomycin, 100 U/mL penicillin, and 10% fetal bovine serum at a concentration of 1×10 6 cells/mL (5% CO 2 , 95% air, 100% humidity). IPEC-J2 cells were grown in plate at 85 95% con uence and then transfected with plasmid DNA encoding porcine HSP70 or empty vector as a control by Lipofectamine ® -3000 (Invitrogen, Shanghai, China).
+ Open protocol
+ Expand
9

CLDN10B Gene Cloning and Verification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CLDN10B was cloned by PCR from a pool of cDNA from human renal biopsy specimens as previously described 17 using CLDN10B-specific primers: forward 5'-GC CGCCATGGCTAGCACG-3'and reverse 5'-GACATAAG-CATTTTTATCAAACTGTT TTGAAGGG-3'. PCR product was subcloned into pcDNA3.1/V5-HIS TOPO TA (Invitrogen, Villebon-sur-Yvette, France). PCR product insertion was verified by enzymatic digestions with EcoRI and BamHI. Construct was confirmed by sequencing (ATGC).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!